Extracorporeal Photopheresis After Liver Transplant

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the safety of photopheresis for prophylaxis of allograft rejection in patients who are being withdrawal immunosuppression after liver transplantation.

Clinical Trial Description

The photopheresis (ECP) is a therapeutic approach based on the biological effect of ultraviolet light A on mononuclear cells collected by apheresis, and reinfused into the patient. ;

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Hepatic Insufficiency

Clinical Trial Details

NCT number	NCT02090621
Study type	Interventional
Source	Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Contact
Status	Completed
Phase	Phase 2
Start date	October 2012
Completion date	March 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04097704` - Pharmacogenetics Sampling of the CC-90007-CP-003 Study Cohort
Completed	`NCT02161224` - A Study to Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver Function	Phase 1
Completed	`NCT00929032` - Liver Transplantation and Reticuloendothelial Clearance Capacity	N/A
Completed	`NCT00509210` - Study of Telaprevir in Subjects With Hepatic Impairment	Phase 1
Completed	`NCT02894385` - Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)	Phase 1
Completed	`NCT03306667` - Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency)	Phase 1
Completed	`NCT04867941` - A Study to Evaluate the Effect of Hepatic Insufficiency on the Pharmacokinetics (PK) of ACP-196	Phase 1
Terminated	`NCT02457702` - Mitochondrial Function in Patients With Severe Liver Disease	N/A
Completed	`NCT02249442` - Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency	Phase 1
Completed	`NCT03341884` - A Study of Ipatasertib in Participants With Mild, Moderate or Severe Hepatic Impairment Compared to Healthy Participants	Phase 1
Completed	`NCT01475136` - A Study of LY2140023 in Hepatically-Impaired Participants	Phase 1
Completed	`NCT00969813` - A Safety and Tolerability Study of CP-690,550 in Subjects With Hepatic Impairment and Normal Hepatic Function	Phase 1
Completed	`NCT00968591` - Pharmacokinetics of Everolimus in Subjects With Hepatic Insufficiency	Phase 1
Completed	`NCT00931060` - Effects of Branched-Chain Amino Acids on Muscle Ammonia Metabolism in Patients With Cirrhosis and Healthy Subjects	N/A
Completed	`NCT00416702` - Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function	Phase 1
Completed	`NCT03968848` - Investigate the Influence of Severe Hepatic Impairment on the Pharmacokinetics of Acalabrutinib and Its Metabolite	Phase 1
Completed	`NCT00692341` - Evaluation Of Hepatic Impairment On AG-013736 Pharmacokinetics	Phase 1
Completed	`NCT00314054` - Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults	Phase 1
Completed	`NCT05731895` - A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Liver Problems	Phase 1
Completed	`NCT03842761` - A Study to Test How Different Doses of BI 685509 Are Tolerated in Patients With Liver Problems	Phase 1